Workflow
Sprouts Farmers Market: A Long-Term Compounder On Sale
Seeking Alpha· 2026-02-27 15:43
Sprouts Farmers Market, Inc. ( SFM ), is presenting one of the best risk-reward opportunities in the market today. I believe Sprouts is a long-term compounder that has become oversold as their comparable store salesAnalyst’s Disclosure: I/we have a beneficial long position in the shares of SFM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business ...
SOUN Posts In-Line Earnings, Strong Revenue Growth in Q4, Stock Up
ZACKS· 2026-02-27 15:42
Key Takeaways SOUN reported 59% Q4 revenue growth to $55.1M, topping estimates as shares rose 3.3% after hours.SoundHound AI improved GAAP and non-GAAP margins, while adjusted EBITDA loss narrowed year over year.SOUN expects 2026 revenues of $225M-$260M, backed by strong pipeline and rising enterprise AI adoption.SoundHound AI, Inc. (SOUN) reported fourth-quarter 2025 results, wherein earnings came in line with the Zacks Consensus Estimate, but revenues surpassed the same.SoundHound AI is gaining momentum a ...
Cactus Q4 Earnings Top Estimates on Higher Pressure Control Revenues
ZACKS· 2026-02-27 15:42
Key Takeaways Cactus Q4 EPS of 65 cents beat estimates on $261M revenues, led by Pressure Control growth.WHD's Pressure Control sales rose on higher product per rig and rental income gains.Spoolable Technologies' revenue fell due to lower activity, though EBITDA topped estimates.Cactus, Inc. (WHD) reported fourth-quarter 2025 adjusted earnings of 65 cents per share, which beat the Zacks Consensus Estimate of 58 cents. The bottom line declined from the year-ago quarter’s figure of 71 cents.Total quarterly re ...
Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus
ZACKS· 2026-02-27 15:42
Key Takeaways Xenon reported a Q4 loss of $1.31 per share, wider than estimates, with no revenues recorded.XENE's R&D expenses rose 47% to $87.7M, driven by late-stage azetukalner studies.Xenon expects its $586M cash to fund phase III epilepsy, MDD and BPD programs into 2027.Xenon Pharmaceuticals (XENE) reported a loss of $1.31 per share for the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.20. The company had incurred a loss of 84 cents per share in the year-ago quarter.In ...
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative
ZACKS· 2026-02-27 15:42
Key Takeaways XRAY rose nearly 7.8% pre-market despite a Q4 earnings miss and margin contraction.DENTSPLY SIRONA posted 6.2% Q4 revenue growth, beating estimates on sales recovery.XRAY unveiled a $120M cost-saving restructuring and will halt dividends to cut debt.DENTSPLY SIRONA Inc. (XRAY) reported fourth-quarter 2025 adjusted earnings per share (EPS) of 27 cents, up 3.8% year over year. The bottom line missed the Zacks Consensus Estimate by 3.6%.GAAP loss per share in the quarter under review was 74 cents ...
Cracker Barrel to Post Q2 Earnings: Weak Traffic, Margin Pressure Loom
ZACKS· 2026-02-27 15:41
Key Takeaways Cracker Barrel to report fiscal Q2 on March 4, with consensus at a 10-cent loss vs $1.38 EPS a year ago.CBRL faces traffic down about 11%, with restaurant comps seen at -6.7% and revenues down 5.7% to $895.8M.Cracker Barrel's adjusted EBITDA is projected to drop 49.5% to $37.7M amid cost deleverage and inflation.Cracker Barrel Old Country Store, Inc. (CBRL) is scheduled to report second-quarter fiscal 2026 results on March 4, 2026.CBRL’s earnings beat the Zacks Consensus Estimate in three of t ...
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
ZACKS· 2026-02-27 15:41
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Allurion Technologies, Inc. (ALUR) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Allurion Technologies, Inc. is a member of our Medical group, which includes 925 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank ...
Aptiv PLC (APTV) is a Top-Ranked Value Stock: Should You Buy?
ZACKS· 2026-02-27 15:41
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are ...
Are Auto-Tires-Trucks Stocks Lagging Michelin (MGDDY) This Year?
ZACKS· 2026-02-27 15:41
The Auto-Tires-Trucks group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Michelin (MGDDY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Auto-Tires-Trucks peers, we might be able to answer that question.Michelin is a member of the Auto-Tires-Trucks sector. This group inc ...
Is Anterix (ATEX) Stock Outpacing Its Computer and Technology Peers This Year?
ZACKS· 2026-02-27 15:41
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Anterix (ATEX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Anterix is a member of our Computer and Technology group, which includes 608 different companies and currently sits at #5 in the Z ...